Jadwal Sholat

Memuat jadwal sholat…

Kedokteran & Kesehatan editorial

Open AccessOA2022

Electroacupuncture vs Sham Electroacupuncture for Postoperative Ileus After Laparoscopic Colorectal Cancer Surgery: A Multicenter Randomized Clinical Trial

In a multicenter, sham-controlled randomized trial of 248 patients undergoing laparoscopic colorectal cancer resection under ERAS, electroacupuncture reduced median time to first defecation by about 8.8 hours and halved the risk of prolonged postoperative ileus compared with sham, with no severe adverse events.
Yu Wang; Jing-Wen Yang; Shi-Yan Yan; Yun Lu; Jia G. Han; W. Pei; Jing-Jie Zhao; Zhi Li; Hang Zhou; Na-Na Yang; Li-Qiong Wang; Ying-Chi Yang; Cun-Zhi Liu· JAMA Surgery· 2022· DOI 10.1001/jamasurg.2022.5674

The core problem

Postoperative ileus (POI) remains a major barrier to recovery after colorectal resection, even with optimized Enhanced Recovery After Surgery (ERAS) protocols. POI prolongs hospital stay, increases discomfort, and adds burden to healthcare systems. Electroacupuncture (EA) has been proposed as a potential adjunct to promote gastrointestinal recovery, but robust evidence from multicenter randomized trials in the ERAS context is limited. This trial aimed to assess whether EA, compared with sham electroacupuncture (SA), reduces the duration of POI in patients undergoing laparoscopic surgery for colorectal cancer when both groups receive standard ERAS care.

Innovation

**Design and setting:** A multicenter, randomized, sham-controlled trial conducted in China from October 12, 2020, through October 17, 2021.

**Participants:** Patients aged 18 years or older undergoing first-time laparoscopic resection of colorectal cancer. A total of 249 patients were randomized; after excluding 1 patient diagnosed with intestinal tuberculosis, 248 patients (mean [SD] age 60.2 [11.4] years; 153 men [61.7%]) were analyzed.

**Randomization and blinding:** 1:1 allocation using a dynamic block random method via a central system. Analyses were by intention to treat.

**Interventions:** Patients were randomly assigned to receive 4 sessions of EA or SA after surgery. All patients were managed within the ERAS protocol.

**Outcomes:** The primary outcome was time to first defecation. Secondary outcomes included other patient-reported outcome measures, length of postoperative hospital stay, readmission rate within 30 days, and incidence of postoperative complications and adverse events.

**Statistical approach:** Between-group comparisons were performed for the primary and secondary outcomes; the primary effect is reported as a mean difference with 95% CI. Prolonged POI was compared using risk ratios.

Introduction
Postoperative ileus (POI) remains a major barrier to recovery after colorectal resection, even with optimized Enhanced Recovery After Surgery (ERAS) protocols. POI prolongs hospital stay, increases discomfort, and adds burden to healthcare systems. Electroacupuncture (EA) has been proposed as a potential adjunct to promote gastrointestinal recovery, but robust evidence from multicenter randomized trials in the ERAS context is limited. This trial aimed to assess whether EA, compared with sham electroacupuncture (SA), reduces the duration of POI in patients undergoing laparoscopic surgery for colorectal cancer when both groups receive standard ERAS care.

Why it matters

This multicenter randomized trial demonstrates that, in patients undergoing laparoscopic colorectal cancer surgery within an ERAS protocol, four sessions of electroacupuncture significantly accelerated gastrointestinal recovery compared with sham electroacupuncture. The primary outcome—time to first defecation—was reduced by nearly 9 hours on average, and secondary recovery milestones (first flatus, tolerance of semiliquid and solid diets) were also achieved earlier. Importantly, the risk of prolonged POI was halved (RR 0.51), suggesting a clinically meaningful benefit in preventing a costly and morbid complication.

The absence of differences in hospital stay and readmission may reflect the already optimized ERAS pathway and the modest absolute reduction in ileus duration; nonetheless, the consistent direction of effect across multiple recovery milestones supports a biological effect of EA. The trial’s strengths include its multicenter design, sham control, intention-to-treat analysis, and high follow-up. Limitations include the single-country setting, the specific EA protocol (4 sessions), and the lack of blinding of outcome assessors for some subjective measures, although the objective primary outcome (defecation) is less susceptible to bias.

Overall, EA appears to be a safe and effective adjunct to ERAS for promoting gastrointestinal function recovery and preventing prolonged POI after laparoscopic colorectal cancer surgery. These findings support consideration of EA as part of multimodal postoperative care in this population.

Who should read this

Pembaca Research Digest dan praktisi rumpun ini.

Opening member content…